Properties | Information | |
---|---|---|
PhytoCAT-ID | PhytoCAT-1659 | |
Phytochemical name or plant extracts | Qingdu granule (QDG) | |
PMID | 1504534 | |
Literature evidence | The average life span of H22, S180, EAC and breast carcinoma-bearing mice treated with TG ip x 2 days were 100% more than those of the control mice (P less than 0.01) TG was able to inhibit tumor growth of S37-bearing mice at the dose of 150 mg/kg per day, ig x 3, its inhibitory rate was 42% (P less than 0.01). | |
IUPAC name | NA | |
Phytochemicals’ class or type of plant extracts | Traditional Chinese herbal prescription | |
Source of phytochemicals or plant Extracts | QDG is composed of eleven herbs, such as Bupleuri Radix | |
Geographical availability | China | |
Plant parts | NA | |
Other cancers | Breast cancer | |
Target gene or protein | VEGF, VEGFR2, NFATc3 | |
Gene or Protein evidence | In breast cancer xenograft model, QDG treatment significantly suppressed tumor growth, inhibited VEGF release, and decreased microvessel density. QDG reduced protein expressions of VEGF, VEGFR2 and NFATc3. | |
Target pathways | NFAT signaling pathway. | |
IC50 | NA | |
Potency | The results suggested that QDG showed anti-angiogenic effects of breast cancer both in vitro and in vivo. | |
Cell line/ mice model | Breast cancer xenograft model | |
Additional information | In breast cancer xenograft model, QDG treatment significantly suppressed tumor growth, inhibited VEGF release, and decreased microvessel density. | |
PubChem ID | NA | |
Additional PMIDs | NA | |
Additional sources of information | NA | |
Safety | NA |